US20040193259A1 - Sizing apparatus for cardiac prostheses and method of using same - Google Patents
Sizing apparatus for cardiac prostheses and method of using same Download PDFInfo
- Publication number
- US20040193259A1 US20040193259A1 US10/396,656 US39665603A US2004193259A1 US 20040193259 A1 US20040193259 A1 US 20040193259A1 US 39665603 A US39665603 A US 39665603A US 2004193259 A1 US2004193259 A1 US 2004193259A1
- Authority
- US
- United States
- Prior art keywords
- contact member
- sectional dimension
- leaflet
- cross
- heart valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2496—Devices for determining the dimensions of the prosthetic valve to be implanted, e.g. templates, sizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/904—Heart
Definitions
- the present invention relates generally to cardiac prostheses and, more particularly, to a sizing apparatus for a cardiac prosthesis and method of using the apparatus.
- a heart valve can become defective or damaged, such as resulting from congenital malformation, disease, or aging. When the valve becomes defective or damaged, the leaflets may not function properly.
- One common problem associated with a degenerating heart valve is an enlargement of the valve annulus (e.g., dilation).
- Other problems that may result in valve dysfunction are chordal elongation and lesions developing on one or more of the leaflets.
- the bicuspid or mitral valve is located in the left atrioventricular opening of the heart for passing blood unidirectionally from the left atrium to the left ventricle of the heart.
- the mitral valve is encircled by a dense fibrous annular ring and includes two valve leaflets of unequal size.
- a larger valve leaflet which is known as the anterior leaflet, is located adjacent the aortic opening.
- the smaller leaflet is the posterior leaflet.
- a mitral valve When a mitral valve functions properly, for example, it prevents regurgitation of blood from the ventricle into the atrium when the ventricle contracts. In order to withstand the substantial backpressure and prevent regurgitation of blood into the atrium during the ventricular contraction, the cusps are held in place by fibrous cords (cordae tendinae) that anchor the valve cusps to the muscular wall of the heart.
- fibrous cords cordae tendinae
- Surgical reconstruction or repair procedures may include plication, chordal shortening, or chordal replacement.
- Another common repair procedure relates to remodeling of the valve annulus (e.g., annuloplasty), which may be accomplished by implantation of a prosthetic ring to help stabilize the annulus and to correct or help prevent valvular insufficiency which may result from defect or dysfunction of the valve annulus.
- Properly sizing and implanting the annuloplasty ring can substantially restore the valve annulus restored to its normal, undilated, circumference.
- the repair or reconstruction of the leaflets may be complicated and time consuming, the results of which are not readily reproducible.
- the present invention relates generally to a sizing apparatus for a prosthetic device intended for implantation at a heart valve to improve operation of a defective or damaged valve.
- the apparatus includes a contact member having a curved surface that is configured to be engaged by one or more functioning leaflets of a heart valve within a patient when the contact member is positioned at the heart valve.
- a user can observe engagement between the functioning leaflet and the contact member to determine an appropriate size of cardiac prosthesis.
- the observations for example, can be made under direct vision (e.g., during an open chest procedure) or via an appropriate vision system (e.g., during an open or closed chest procedure).
- the cross-sectional dimension of the contact member can be changed, such as by either employing a different contact member or by using a contact member in which the size of the curved surface is adjustable, until an appropriate size is can be determined.
- a user may be able to gauge an appropriate size based on observed a sizing discrepancy between the leaflet and the contact member.
- An appropriately sized prosthetic device can then be implanted based on the sizing.
- a sizing apparatus for a prosthetic device includes a contact member and an elongated member extending from the contact member and terminating in a proximal end.
- the contact member includes a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve.
- the elongated member includes an aperture extending through from a proximal end of the elongated member and terminating in an opening proximal the contact member. The aperture facilitates the flow of fluid through the contact member into a chamber of the heart to urge the functioning leaflet toward the contact member.
- a sizing apparatus for a prosthetic device includes a contact member and an elongated member extending from the contact member and terminating in a proximal end.
- the contact member includes a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve.
- the contact surface is configured to have a variable cross-sectional dimension.
- the contact surface can assume at least a reduced cross-sectional dimension to facilitate positioning of the contact member at the heart valve.
- the contact surface can be selectively expanded to an expanded cross sectional dimension, such that the at least one leaflet can engage the contact member to facilitate determining the size of a desired cardiac prosthesis.
- FIG. 1 is an elevated side view of an example apparatus in accordance with an aspect of the present invention.
- FIG. 2 is a cross-sectional view of the taken along line 2 - 2 of FIG. 1.
- FIG. 3 is a view of the apparatus taken along line 3 - 3 of FIG. 2.
- FIG. 4 is a cross-sectional view of the apparatus positioned within the heart valve of a patient, illustrating a first condition of the heart valve.
- FIG. 5 is an overhead (inflow) view of the apparatus positioned within the heart valve of a patient, illustrating a first condition of the heart valve.
- FIG. 6 is a cross-sectional view of the apparatus positioned within the heart valve of a patient, similar to FIG. 4, illustrating a second condition of the heart valve.
- FIG. 7 is an overhead (inflow) view of the heart valve and the apparatus, similar to FIG. 5, illustrating a second condition of the heart valve.
- FIG. 8 is an assembly view of an apparatus in accordance with an aspect of the present invention with a contact member detached from the elongated member.
- FIG. 9 is an example of a contact member in accordance with an aspect of the present invention.
- FIG. 10 is another example of a contact member in accordance with an aspect of the present invention.
- FIG. 11 is an isometric view of a cardiac prosthesis that can be employed in accordance with an aspect of the present invention.
- FIG. 12 is a cross-sectional view of a part of a heart in which the cardiac prosthesis is implanted at a heart valve in accordance with an aspect of the present invention.
- FIG. 13 is an elevated side view of a sizing apparatus in accordance with another aspect of the present invention.
- FIG. 14 is an overhead view of a sizing apparatus in accordance with yet another aspect of the present invention.
- the present invention relates generally to a sizing apparatus for a cardiac prosthesis.
- the sizing apparatus can be used to determine the appropriate size for a cardiac prosthesis (e.g., a valvuloplasty device) that can be implanted into the heart valve to cooperate with at least one of the leaflets of the patient's own valve, which can be the patient's native valve or a previously implanted prosthesis.
- the sizing tool of the present invention includes a contact member that can be engaged by one or more viable leaflets of a patient's heart valve to ascertain the proper size for a cardiac prosthesis.
- FIGS. 1-3 illustrate a sizing apparatus 10 in accordance with one aspect of the invention.
- the apparatus 10 includes a contact member 12 .
- the contact member 12 has a curved surface 14 configured to be engaged by a leaflet within a heart valve.
- the curved surface 14 can be configured to engage the anterior leaflet of the mitral valve of a patient's heart.
- the contact member 12 can be fabricated from any substantially rigid, durable material that is substantially biocompatible.
- substantially rigid it is meant that the contact member 12 should be capable of holding its basic shape under a moderate amount of pressure.
- durable it is meant that the device should be able to withstand standard sterilization techniques, such as by an autoclave or other sterilizer.
- Example materials that can be used for the contact member include durable plastics (e.g., formed of DELRIN®) and non-reactive metals, such as surgical steel. Those skilled in the art will understand and appreciate other types of materials that also could be employed to form the contact member, all of which are contemplated as falling within the scope of the present invention.
- An elongated member 16 extends from the contact member 12 to terminate in a proximal end 20 that is spaced apart from the contact member.
- the elongated member is depicted as a generally cylindrical, elongated rod or tube, which can be hollow.
- an aperture 22 extends through the elongated member 16 from its proximal end 20 to an opening located near a surface 18 of the contact member 12 opposite the surface 14 .
- the elongated member 16 can be formed of a durable and generally rigid material.
- the elongated member 16 can be formed of the same or a different material than the contact member 12 .
- the length and composition of the elongated member 16 can vary, depending on the application. For example, some applications can require a lengthy elongated member 16 or an elongated member formed form a more flexible material. Those skilled in the art will appreciate that different materials and lengths can be selected depending on the design of the device and the desired application.
- the elongated member 16 can also be formed of multiple portions, which can be the same or different materials.
- the elongated member illustrated in FIG. 2 begins at its proximal end 20 as a plastic material.
- the inside of that portion of elongated member can be threaded (or otherwise configured) to accept a spout 24 , which can be made from stainless steel (or any other generally rigid material) that terminates near the contact member 12 .
- the contact member 12 can be formed from a single material, such as a metal or plastic material.
- the contact member 12 is dimensioned to a size consistent with that of a leaflet within a heart valve.
- a contact member 12 approximating the size of a leaflet within an adult human mitral valve can have a width (indicated at W in FIG. 3) ranging from fifteen to fifty millimeters.
- W in FIG. 3 a width ranging from fifteen to fifty millimeters.
- the width of the contact member can vary according to the application. For example, in a heart valve sizing apparatus intended for use in children or small animals, a width smaller than fifteen millimeters may be appropriate. An apparatus intended for use in large animals, such as horses, might require a contact member with a width greater than fifty millimeters.
- a longitudinal axis 26 extends longitudinally through the elongated member 16 substantially parallel to the aperture 22 . While the member 16 is depicted as being substantially straight, it will be appreciated that it alternatively could be curved or formed a flexible material to facilitate curving the member.
- the contact surface 14 is curved in a convex manner relative to the axis 26 .
- Another axis 28 shown in FIG. 3, is substantially perpendicular to the axis 26 and coincides with the longest dimension (e.g., the width W) of the contact member 12 .
- the contact surface 14 is curved relative to the horizontal axis 28 in a concave manner (e.g., curves away). As a result of this curvature, the contact member 12 is configured to approximate a leaflet of a heart valve at closure of the valve.
- the proximal end 20 of the elongated member 16 can connect to a sleeve-like conduit interface 30 , as depicted in FIG. 1.
- the conduit interface 30 can be made from any durable, flexible material that is substantially biocompatible. Example materials include rubber or silicon, although other types of materials can also be used.
- the proximal end 32 of the conduit interface 30 is adapted to connect to a fluid source 34 , which can include a syringe or other type of device capable of injecting fluid through the aperture 22 . This adaptation allows the conduit interface 30 to fit tightly over a nozzle 36 of the fluid source 34 , while the other end 37 of the conduit interface connects to the proximal end 20 of the elongated member 16 .
- the conduit interface 30 thus can interconnect the elongated member 16 and the nozzle 36 to provide a substantially fluid-tight seal to enable the flow of fluids therethrough.
- the fluid source 34 contains a quantity of a fluid that can be passed through the aperture 22 of the elongated member 16 .
- a number of fluids can be used, including air, water, saline, and blood to name a few.
- the fluid source includes a syringe 38 .
- the syringe 38 can be used to expel fluid from the fluid source 34 through the nozzle 36 and into the aperture 22 of the elongated member 16 .
- One skilled the art will perceive other devices for controlling the flow of fluid from the fluid source, such as stop cocks and mechanical or electric pumps, and the use of these devices is intended to be encompassed within the claimed invention.
- the fluid source 34 can be formed from a number of materials. For example, transparent materials, such as clear plastics and glass, can be used, as they allow a user to determine more easily the fluid level within the fluid source 34 .
- implantation of a prosthesis can include the use of a sizing tool 52 to ascertain an appropriate size for a prosthetic device in accordance with an aspect of the present invention.
- the sizing tool 52 has been inserted into a heart valve 54 .
- the valve 54 is illustrated in FIGS. 4-12 as a mitral valve within a human heart, and the method is discussed in the context of implanting a prosthesis to replace the posterior leaflet within the mitral valve.
- the apparatus of the present invention may be used in other valves within the human heart, such as the tricuspid, pulmonary, or aortic valves, as well as in valves within animal hearts.
- the present invention may be used to size a replacement for any leaflet, including the anterior leaflet of the mitral valve or the leaflets of any of the aforementioned valves. Such uses are intended to be encompassed in the appended claims.
- the chamber above the mitral valve 54 is the left atrium 56 and the chamber below the valve is the left ventricle 58 .
- the anterior leaflet 60 is present and viable, but the posterior leaflet (not shown) is either nonviable or has been removed.
- a contact member 62 of the sizing tool 52 is positioned at the position formerly occupied by the posterior leaflet, with a contact surface 64 facing the anterior leaflet 60 .
- the contact member 62 can be positioned manually by a user holding an elongated handle 66 or other structure attached to the member.
- An inflow view of the open valve 54 and sizing apparatus 52 is shown in FIG. 5.
- the user would employ a fluid source 68 in fluid communication with the apparatus 52 to supply fluid into the ventricle 58 .
- fluid thus flows through an aperture 70 within the elongated handle 66 into the left ventricle 58 .
- this can be accomplished by a number of methods, such as a pump, syringe, or a stopcock.
- the anterior leaflet 60 is urged toward its closed position and toward the contact member 62 .
- the anterior leaflet 60 can engage with the contact member 62 to close the valve, as illustrated in FIG. 6.
- a size of a corresponding prosthesis can be determined according to the size of the contact member 62 .
- An inflow view of a leaflet 60 coapting with a contact member 62 is illustrated in FIG. 7.
- the surgeon will know that a prosthetic device matching the size and shape of the contact member 62 is appropriate for a prosthetic replacement. Where there is not sufficient coaptation between the leaflet 60 and the contact member 62 , a differently sized prosthesis should be used.
- the surgeon may see small spaces or gaps between the leaflet and the contact member. This indicates a larger size prosthesis may be needed. This can be confirmed by repeating the sizing process with a larger sized contact member.
- the annulus of the valve 54 may distort, thereby preventing desired coaptation between the contact member 62 and the leaflet. Additionally or alternatively, the orifice between the contact member 62 and the leaflet may be considered be too small. A surgeon thus can readily ascertain that a prosthetic device matching the size of the contact member would be too large and seek a smaller device.
- FIG. 8 illustrates an apparatus 80 is provided where a contact member 82 can be made selectively detachable from an elongated member 84 In accordance with an aspect of the present invention.
- the selective attachment allows a surgeon to select from a number of alternate contact members of different size if the original contact member 82 is too large or too small.
- the distal end of the elongated member 84 can be threaded to allow a contact member to be screwed onto the elongated member.
- connections or fittings e.g., friction fitting, snap fitting, and the like).
- FIGS. 9 and 10 illustrate examples of alternative contact members, 86 and 88 .
- the surgeon can repeat the sizing procedure described above to better approximate the size of an appropriate prosthetic leaflet.
- a desired one of the contact members 82 , 86 , 88 can be attached to the elongated member by any of a number of means known in the art.
- FIG. 11 illustrates an example of a cardiac prosthesis 100 that can be implanted according to the present method.
- the prosthesis 100 can be of the type shown and described in U.S. patent application Ser. No. 10/215,800, filed on Aug. 4, 2002, to Gabbay, which is hereby incorporated by reference.
- the prosthesis 100 includes a generally arcuate base portion 102 that can be closed or C-shaped.
- a section of the base portion can be removable from the prosthesis 100 (e.g., by cutting) so that a surgeon can select the type of annulus desired—ring-like or C-shaped.
- the base portion 102 includes a support ring, which can be formed of a flexible, resilient, or generally rigid material. The support ring can have an elastic property that returns the ring to its original shape when deflected from its original (or rest) condition.
- the support ring for example, can be a plastic-like material (e.g., a polymer, a resin, etc.) or a metal (e.g., stainless steel, a shape memory alloy, such as NITINOL), such as in the form of a wire.
- a plastic-like material e.g., a polymer, a resin, etc.
- a metal e.g., stainless steel, a shape memory alloy, such as NITINOL
- a suitable inelastically deformable material also could be used to form the support ring.
- a buttress 104 extends generally axially from an outflow side 106 of the base portion 102 .
- a proximal portion 108 of the buttress 104 extends generally axially and radially inward from the base portion 102 .
- a distally extending portion 110 of the buttress 104 extends from the proximal portion 108 and curves radially outwardly therefrom for the remaining length of the buttress.
- the buttress 104 has a radially inner surface 112 that provides a surface against which a leaflet (e.g., an anterior leaflet of a mitral valve) can coapt at valve closure.
- the prosthesis 100 including the buttress 104 , can be selected according to the dimensions and configuration of a contact member from a sizing apparatus that has been determined to provide desired coaptation. Consequently, when the prosthesis 100 is implanted within a heart valve, a leaflet (or leaflets) can engage the buttress 104 to close the valve and provide substantially unidirectional flow of blood therethrough. The leaflet (or leaflets) is able to coapt with the inner surface 112 of the buttress 104 , thereby inhibiting regurgitation of blood when the ventricle contracts.
- the prosthesis 100 can also include an outer sheath 114 of a flexible, biocompatible material covering the apparatus.
- the apparatus 100 also can include an implantation flange 116 (or sewing ring) that circumscribes the base portion 102 of the apparatus.
- the implantation flange 116 extends radially outwardly from the base portion 102 for facilitating implantation of the apparatus 100 at a heart valve.
- Each of the outer sheath 114 and the implantation flange 116 can be formed of any suitable flexible, biocompatible material, such as a cloth-like or fabric (natural or synthetic) material or a biological material, such as collagen or an animal tissue material.
- An acceptable animal tissue material is smooth animal pericardium (e.g., equine, bovine, porcine, etc.), such as a NO-REACT® tissue product, which is available from Shelhigh, Inc. of Union, N.J.
- Implantation of a cardiac prosthesis can be accomplished by several means. For the type of prosthesis illustrated in FIG. 11, these means will generally require open heart surgery.
- the base portion 102 can be sewn to the wall of the valve 54 at the implantation flange 116 to hold the prosthesis in place.
- the base portion 102 can also include barbs or hooks (not shown) that extend radially from the exterior of the base potion, such as disclosed in the above incorporated Gabbay patent application. These barbs can be pressed into the wall of the valve to directly engage the muscle tissue of the valve.
- a prosthesis can be designed to be reducible to a smaller cross-sectional dimension for placement via a catheter or a type of implantation.
- the sizing tool and process used for these non-invasive techniques can vary from those described above, in accordance with additional aspects of the present invention.
- FIG. 12 illustrates a part of a heart in which a prosthesis 130 is implanted at a mitral valve 132 .
- the implanted prosthesis will be the type of prosthesis 100 illustrated in FIG. 11, but in which the removable section 103 of the annular base 102 has been removed. It will be appreciated, however, that the present invention is not limited to use with this prosthesis. A number of other cardiac prostheses are available and suitable for use with the sizing apparatus of the present invention.
- the valve 132 facilitates a unidirectional flow of blood from the left atrium 134 into the left ventricle 136 .
- the mitral valve 132 includes an anterior leaflet 138 that extends from the valve opening and attaches to muscular tissue in the wall of the left ventricle by fibrous cordae tendinae 140 .
- a posterior leaflet (not shown) extends from an opposing surface of the valve opening and coapts the anterior leaflet at valve closure.
- the posterior leaflet has been substantially removed from the heart, such as by excising it before implanting the prosthesis 130 . It is to be understood and appreciated, however, that the posterior leaflet can remain intact, with a buttress 142 of the prosthesis 130 interposed between the posterior and anterior leaflets.
- the buttress 142 extends from a base 144 of the prosthesis 130 into the ventricle 136 at a position corresponding to the position of the posterior leaflet of the mitral valve 132 .
- the buttress 142 extends into the ventricle 136
- the buttress 142 can be formed of a generally rigid material that remains substantially stationary (e.g., static) during both the open and closed positions of the valve.
- the buttress 142 can be a sufficiently flexible- material to permit movement thereof commensurate with the flow of blood from the atrium 136 into the ventricle 136 through the valve 132 .
- FIG. 12 illustrates the anterior leaflet 138 engaging the buttress 142 of the prosthesis 130 , operating as a closed valve.
- the buttress 142 of the prosthesis 130 simulates the function of the posterior leaflet at valve closure by providing a surface against which the anterior leaflet 138 coapts. Consequently, the buttress 142 and the anterior leaflet 138 cooperate to inhibit regurgitation of blood from the left ventricle 136 into the left atrium 136 , such as during ventricular contraction.
- the buttress 142 in conjunction with the anterior leaflet 138 , facilitates and promotes unidirectional flow of blood when the valve is open.
- an opening or aperture extends through the implanted prosthesis 130 between the buttress 142 and the anterior leaflet 138 .
- the movement of the anterior leaflet 138 relative to the buttress 142 in response to the flow of blood during the contraction of the left atrium 136 , provides a sufficient orifice to permit the substantially free flow of blood from the left atrium into the left ventricle 136 .
- the buttress 142 also can be formed of a flexible material that is able to move radially relative to the base portion 144 to further facilitate blood flow.
- FIG. 13 illustrates an apparatus 150 in accordance with another aspect of the invention.
- the apparatus 150 includes a contact member 152 .
- the contact member 152 can be capable of assuming multiple configurations having different associated cross-sectional dimensions.
- the contact member has a curved surface 154 with an associated shape and area varying with the configuration of the contact member 152 .
- the cross-sectional width dimension is shown to vary between W 1 and W 2 , where W 1 >W 2 .
- the curved surface 154 is shaped to engage a leaflet within a heart valve.
- the contact member 152 can be made from a material having with a natural shape and a tendency to return to that natural shape in the absence of a deforming force and the capacity to be deformed from that natural shape by pressure or some other means.
- the contact member can be formed from a shape memory alloy material, such as Nitinol. Such an alloy can be formed into a particular shape and treated to allow it to “remember” that form. At low temperatures, the material remains pliant, but at higher temperatures, such as those within a patient's body, the material will attempt to revert to the remembered form.
- the shape memory alloy can be coated with natural or synthetic material, such as a soft plastic, rubber or biological material (e.g., animal pericardium, dura matter, etc.).
- the natural shape of the material corresponds to the configuration of the contact member having the largest cross-sectional dimension W 1 . It will be appreciated, however, that the apparatus may be designed such that the natural shape is the configuration with the smallest cross-sectional dimension W 2 or an intermediate cross-sectional dimension, depending on the requirements of a given application.
- the illustrated contact member 152 can be deformed into a configuration having a smaller cross-sectional dimension (e.g., less than W 1 ) by one or more control members.
- the control members include one or more elongated restraints 156 and 158 , such as sutures. It will be appreciated that the one or more control members of the device may take a number of forms, and that the illustrated device is merely exemplary.
- the restraints are connected at their distal ends to the lateral edges 160 and 162 of the contact member 152 to hold the contact member in a configuration having a reduced cross-sectional dimension.
- An elongated member 159 extends from the contact member 152 to a proximal end (not shown).
- One or more apertures extend through the elongated member 159 from its proximal end 162 to a point near the contact surface 154 of the contact member 152 .
- the restraints 156 and 158 extend through one or more orifices 164 and 166 into the aperture within the elongated member 159 at a point near the contact surface 154 .
- the restraints 156 and 158 extend through the aperture to a proximal end 162 of the elongated member 160 .
- the restraints 156 and 158 can be fastened by their proximal ends to a control device (not shown) to maintain a necessary tension within the restraints 156 and 158 to deform the contact member 152 .
- the configuration of the contact member 152 can be controlled by the control device at the proximal end of the elongated member 159 .
- the control device is operative to increase or decrease the length of the restraints 156 and 158 between the proximal end 162 of the elongated member 159 and the lateral edges 160 and 162 of the contact member 152 .
- the restraints operate to pull the lateral edges closer together, reducing the cross-sectional dimension of the contact member (e.g., to less than W 1 ).
- the lateral edges will move apart as the contact member 152 attempting to return to its natural configuration (e.g., W 1 ).
- the expanded size thus will vary according to the length of the restraints between the apertures 164 and 166 and the respective lateral edges 160 and 162 .
- control device can include any of a number of devices useful in controlling the tension on the restraints 156 and 158 .
- one or more wheels can gather a portion of the restraints 156 and 158 into a coil under manual or mechanical pressure.
- one or more restraining clips on the exterior of the device can be employed to enable the user to withdraw or release a portion of the restraints manually and clip the restraints into place at a desired length. Similar examples should be apparent to one skilled in the art in light of the foregoing discussion.
- markings or indicia can be provided on the device, for example, on the device exterior, to directly or indirectly measure the length of the restraints 156 and 158 between the proximal end 162 and the lateral edges 160 and 162 of the contact member 152 .
- the apparatus 150 can be calibrated such that a particular length of one or more of the restraints 156 and 158 will correspond to a cross-sectional dimension of the contact member 152 , allowing the cross-sectional dimension to be determined from the measurement of the length of the one or more restraints.
- An intended purpose of the apparatus 150 of FIG. 13 is its use in a minimally invasive sizing process to precede implantation of a valvuloplasty device, such as shown and described in the above-incorporated Gabbay patent application.
- the illustrated contact member 152 can be deformed to a configuration having a reduced cross-sectional dimension to facilitate placement of the device.
- the apparatus 150 can be mounted to a catheter, an elongated handle, or another positioning device for insertion into a heart valve.
- An appropriate vision system can be included with the apparatus 150 to guide the placement of the apparatus 150 and determine if a particular configuration of the contact member provides effective coaptation with any viable leaflets in the valve.
- a low invasive minithoracotomy can be used to gain access to the heart of the patient and the apparatus 150 can be inserted through the minithoracotomy passage.
- the contact member 152 is first placed into a configuration having a minimal cross-sectional dimension. The surgeon can then guide the apparatus 150 through the passage using an appropriate vision system to bring the contact member 152 into a desired position for engaging with any viable leaflets of the valve.
- the cross-sectional dimension of the contact member can then be expanded to the size where it engages with the viable leaflets and the cross-sectional dimension necessary to provide effective coaptation can be recorded. The point where effective coaptation takes place can be determined by the surgeon using the vision system.
- the cross-sectional dimension of the contact member 152 can then be reduced back to its initial, minimal configuration to facilitate withdrawal of the device. It will be appreciated that such a procedure can be implemented with little or no cardiopulmonary bypass.
- the apparatus 150 can be inserted into the heart valve from a remote entry point within the body.
- an electromechanical mechanism can be used to adjust the length of the restraints 156 and 158 and accordingly, adjust the configuration of the contact member 152 , as the restraints 156 and 158 may not be in a position to be manually adjusted.
- the cross-sectional dimension of the contact member 152 can be reduced to facilitate passage through blood vessels into the valve, and expanded to measure the size of a prosthetic replacement necessary to provide effective coaptation of any viable leaflets. The cross-sectional dimension of the contact member 152 can then be reduced to allow the apparatus 150 to be removed.
- FIG. 14 illustrates an apparatus 210 in accordance with another aspect of the invention.
- the apparatus 210 includes a contact member 212 .
- the contact member 212 is capable of assuming a plurality (e.g., at least two) configurations, each having a different associated cross-sectional dimension. Two such dimensions are depicted at W 1 and W 2 , where W 1 >W 2 .
- the contact member 212 has a curved surface 214 with an associated shape and area varying with the configuration of the contact member 212 .
- the size contact member 212 thus is variable to accommodate differently sized heart valves.
- the contact member can be provided in a sufficiently reduce cross-sectional dimension to facilitate its positioning at a patient's heart valve by minimally invasive means according to an aspect of the present invention.
- the contact member 212 (or at least the surface 214 thereof) is formed from a fluid impermeable membrane 241 defining an interior chamber.
- the outer membrane 241 can be formed from rubber, flexible plastic, or any other elastic, fluid-impermeable substance that is substantially biocompatible.
- the interior chamber of the member 212 is connected to a fluid source (not shown) that can be located near the proximal end of the elongated member 244 through a conduit 245 or other fluid communicating member.
- the conduit 245 for example, can be formed as an aperture extending through the elongated member 244 .
- a control device (not shown) on the fluid source directs a fluid through the aperture 245 to the interior chamber.
- This mechanism can be a pump, a syringe, a bellows, or any similar device for encouraging the flow of fluid.
- the fluid itself may be air, water, saline, blood, or any other biocompatible fluid.
- the cross-sectional dimension of the contact member 212 can be ascertained according to the amount of fluid that is directed into the interior chamber.
- the apparatus 210 can be calibrated such that a particular fluid level can be translated into an appropriate cross-sectional dimension.
- a control device can include means for evacuating the fluid within the interior chamber, either back into the fluid source, or into the heart valve.
- An intended purpose of the apparatus 210 illustrated in FIG. 14 is its use in a minimally invasive sizing process to precede implantation of a valvuloplasty device.
- the contact member 212 begins with the outer membrane 241 deflated to provide a reduced cross-sectional dimension that facilitates placement of the device.
- the apparatus 210 can be mounted to a catheter, an elongated handle, or another positioning device for insertion into a heart valve.
- the fluid source can connect to the contact member 212 through an aperture 246 in the elongated member 244 .
- An appropriate vision system can be included with the device to guide the placement of the device and determine if a particular configuration of the contact member 212 provides effective coaptation with any viable leaflets in the valve.
- a low invasive minithoracotomy can be used to gain access to the heart of the patient, such that the apparatus 210 can be inserted through the minithoracotomy passage.
- the contact member 212 is placed in a deflated configuration having a minimal cross-sectional dimension to facilitate positioning of the device. The surgeon can then guide the apparatus 210 through the passage using an appropriate vision system to place the contact member 212 at a desired position for engaging one or more viable leaflets of the valve.
- the cross-sectional dimension of the contact member 212 can then be selectively expanded through inflation of the outer membrane 241 to the point where the viable leaflets can engage the surface 214 to inhibit flow of fluid through the valve annulus (e.g., simulating operation of competent heart valve).
- the cross-sectional dimension necessary to provide effective coaptation can be recorded based on the amount of fluid provided to the inner chamber, for example.
- the coaptation between the contact member and the valve leaflet (or leaflets) can be determined by the surgeon using the vision system.
- the cross-sectional dimension of the contact member 212 can then be reduced back to its initial, minimal configuration to facilitate withdrawal of the device by evacuating the fluid within the device. It will be appreciated that such a procedure can be implemented with little or no cardiopulmonary bypass.
- the apparatus 210 can be mounted to a catheter for insertion into the heart valve from a remote entry point of the body.
- a separate tube can be included to carry fluid to the interior chamber from the fluid source to adjust the configuration of the contact member 212 .
- the cross-sectional dimension of the contact member 212 is placed in a reduced form to facilitate passage through blood vessels into the valve.
- the inner chamber of the contact member 212 is then filled at least partially with fluid to expand the contact member 212 to determine a suitable size of a prosthetic device to provide effective coaptation of any viable leaflets.
- the cross-sectional dimension of the contact member 212 can then be reduced to allow the apparatus 210 to be removed by evacuating the fluid from the inner chamber.
- an apparatus provides a useful apparatus for determining the necessary size for a valvuloplasty device intended for implantation into a heart valve.
- a method for utilizing the apparatus for sizing a heart valve has been described.
- Embodiments of the apparatus that are useful for a minimally invasive sizing procedure have been provided.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Dentistry (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
Abstract
A sizing apparatus and a method for ascertaining a size for a cardiac prosthesis are disclosed. Specifically, the sizing is implemented by positioning a contact member at a patient's heart valve for engagement by one or more viable leaflets of the patient's valve. The size is determined based on the engagement between the contact member and the leaflet (or leaflets) of the patient's valve.
Description
- The present invention relates generally to cardiac prostheses and, more particularly, to a sizing apparatus for a cardiac prosthesis and method of using the apparatus.
- A heart valve can become defective or damaged, such as resulting from congenital malformation, disease, or aging. When the valve becomes defective or damaged, the leaflets may not function properly. One common problem associated with a degenerating heart valve is an enlargement of the valve annulus (e.g., dilation). Other problems that may result in valve dysfunction are chordal elongation and lesions developing on one or more of the leaflets.
- The bicuspid or mitral valve is located in the left atrioventricular opening of the heart for passing blood unidirectionally from the left atrium to the left ventricle of the heart. The mitral valve is encircled by a dense fibrous annular ring and includes two valve leaflets of unequal size. A larger valve leaflet, which is known as the anterior leaflet, is located adjacent the aortic opening. The smaller leaflet is the posterior leaflet.
- When a mitral valve functions properly, for example, it prevents regurgitation of blood from the ventricle into the atrium when the ventricle contracts. In order to withstand the substantial backpressure and prevent regurgitation of blood into the atrium during the ventricular contraction, the cusps are held in place by fibrous cords (cordae tendinae) that anchor the valve cusps to the muscular wall of the heart.
- By way of example, if an annulus enlarges or dilates to a point where the attached leaflets are unable to fully close (malcoaptation), regurgitation or valve prolapse might occur. Adverse clinical symptoms, such as chest pain, cardiac arrhythmias, dyspnea, may manifest in response to valve prolapse or regurgitation. As a result, surgical correction, either by valve repair procedures or by valve replacement, may be required.
- Surgical reconstruction or repair procedures may include plication, chordal shortening, or chordal replacement. Another common repair procedure relates to remodeling of the valve annulus (e.g., annuloplasty), which may be accomplished by implantation of a prosthetic ring to help stabilize the annulus and to correct or help prevent valvular insufficiency which may result from defect or dysfunction of the valve annulus. Properly sizing and implanting the annuloplasty ring can substantially restore the valve annulus restored to its normal, undilated, circumference. In situations where the valve leaflets exhibit lesions, it also may be necessary to reconstruct one or more valve leaflets by securing grafts or patches to the leaflets, such as over lesions or holes formed in the leaflet. The repair or reconstruction of the leaflets may be complicated and time consuming, the results of which are not readily reproducible.
- The following presents a simplified summary of the invention in order to provide a basic understanding of some aspects of the invention. This summary is not an extensive overview of the invention. It is intended to neither identify key or critical elements of the invention nor delineate the scope of the invention. Its sole purpose is to present some concepts of the invention in a simplified form as a prelude to the more detailed description that is presented later.
- The present invention relates generally to a sizing apparatus for a prosthetic device intended for implantation at a heart valve to improve operation of a defective or damaged valve. The apparatus includes a contact member having a curved surface that is configured to be engaged by one or more functioning leaflets of a heart valve within a patient when the contact member is positioned at the heart valve. A user can observe engagement between the functioning leaflet and the contact member to determine an appropriate size of cardiac prosthesis. The observations, for example, can be made under direct vision (e.g., during an open chest procedure) or via an appropriate vision system (e.g., during an open or closed chest procedure). Additionally, where the curved surface is not of an appropriate size, the cross-sectional dimension of the contact member can be changed, such as by either employing a different contact member or by using a contact member in which the size of the curved surface is adjustable, until an appropriate size is can be determined. Alternatively, a user may be able to gauge an appropriate size based on observed a sizing discrepancy between the leaflet and the contact member. An appropriately sized prosthetic device can then be implanted based on the sizing.
- In accordance with another aspect of the invention, a sizing apparatus for a prosthetic device includes a contact member and an elongated member extending from the contact member and terminating in a proximal end. The contact member includes a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve. The elongated member includes an aperture extending through from a proximal end of the elongated member and terminating in an opening proximal the contact member. The aperture facilitates the flow of fluid through the contact member into a chamber of the heart to urge the functioning leaflet toward the contact member.
- In accordance with yet another aspect of the invention, a sizing apparatus for a prosthetic device includes a contact member and an elongated member extending from the contact member and terminating in a proximal end. The contact member includes a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve. The contact surface is configured to have a variable cross-sectional dimension. The contact surface can assume at least a reduced cross-sectional dimension to facilitate positioning of the contact member at the heart valve. The contact surface can be selectively expanded to an expanded cross sectional dimension, such that the at least one leaflet can engage the contact member to facilitate determining the size of a desired cardiac prosthesis.
- To the accomplishment of the foregoing and related ends, the invention, then, comprises the features hereinafter fully described and particularly pointed out in the claims. The following description and the annexed drawings set forth in detail certain illustrative aspects of the invention. These aspects are indicative, however, of but a few of the various ways in which the principles of the invention may be employed. Other objects, advantages and novel features of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the drawings.
- FIG. 1 is an elevated side view of an example apparatus in accordance with an aspect of the present invention.
- FIG. 2 is a cross-sectional view of the taken along line2-2 of FIG. 1.
- FIG. 3 is a view of the apparatus taken along line3-3 of FIG. 2.
- FIG. 4 is a cross-sectional view of the apparatus positioned within the heart valve of a patient, illustrating a first condition of the heart valve.
- FIG. 5 is an overhead (inflow) view of the apparatus positioned within the heart valve of a patient, illustrating a first condition of the heart valve.
- FIG. 6 is a cross-sectional view of the apparatus positioned within the heart valve of a patient, similar to FIG. 4, illustrating a second condition of the heart valve.
- FIG. 7 is an overhead (inflow) view of the heart valve and the apparatus, similar to FIG. 5, illustrating a second condition of the heart valve.
- FIG. 8 is an assembly view of an apparatus in accordance with an aspect of the present invention with a contact member detached from the elongated member.
- FIG. 9 is an example of a contact member in accordance with an aspect of the present invention.
- FIG. 10 is another example of a contact member in accordance with an aspect of the present invention.
- FIG. 11 is an isometric view of a cardiac prosthesis that can be employed in accordance with an aspect of the present invention.
- FIG. 12 is a cross-sectional view of a part of a heart in which the cardiac prosthesis is implanted at a heart valve in accordance with an aspect of the present invention.
- FIG. 13 is an elevated side view of a sizing apparatus in accordance with another aspect of the present invention.
- FIG. 14 is an overhead view of a sizing apparatus in accordance with yet another aspect of the present invention.
- The present invention relates generally to a sizing apparatus for a cardiac prosthesis. The sizing apparatus can be used to determine the appropriate size for a cardiac prosthesis (e.g., a valvuloplasty device) that can be implanted into the heart valve to cooperate with at least one of the leaflets of the patient's own valve, which can be the patient's native valve or a previously implanted prosthesis. Specifically, the sizing tool of the present invention includes a contact member that can be engaged by one or more viable leaflets of a patient's heart valve to ascertain the proper size for a cardiac prosthesis.
- FIGS. 1-3 illustrate a sizing
apparatus 10 in accordance with one aspect of the invention. Theapparatus 10 includes acontact member 12. Thecontact member 12 has acurved surface 14 configured to be engaged by a leaflet within a heart valve. For example, thecurved surface 14 can be configured to engage the anterior leaflet of the mitral valve of a patient's heart. - In accordance with the present aspect of the invention, the
contact member 12 can be fabricated from any substantially rigid, durable material that is substantially biocompatible. By substantially rigid, it is meant that thecontact member 12 should be capable of holding its basic shape under a moderate amount of pressure. By durable, it is meant that the device should be able to withstand standard sterilization techniques, such as by an autoclave or other sterilizer. Example materials that can be used for the contact member include durable plastics (e.g., formed of DELRIN®) and non-reactive metals, such as surgical steel. Those skilled in the art will understand and appreciate other types of materials that also could be employed to form the contact member, all of which are contemplated as falling within the scope of the present invention. - An
elongated member 16 extends from thecontact member 12 to terminate in aproximal end 20 that is spaced apart from the contact member. In the example of FIGS. 1-3, the elongated member is depicted as a generally cylindrical, elongated rod or tube, which can be hollow. As shown in FIG. 2, anaperture 22 extends through theelongated member 16 from itsproximal end 20 to an opening located near asurface 18 of thecontact member 12 opposite thesurface 14. - The elongated
member 16 can be formed of a durable and generally rigid material. Theelongated member 16 can be formed of the same or a different material than thecontact member 12. The length and composition of theelongated member 16 can vary, depending on the application. For example, some applications can require a lengthyelongated member 16 or an elongated member formed form a more flexible material. Those skilled in the art will appreciate that different materials and lengths can be selected depending on the design of the device and the desired application. - The elongated
member 16 can also be formed of multiple portions, which can be the same or different materials. For example, the elongated member illustrated in FIG. 2 begins at itsproximal end 20 as a plastic material. The inside of that portion of elongated member can be threaded (or otherwise configured) to accept aspout 24, which can be made from stainless steel (or any other generally rigid material) that terminates near thecontact member 12. Alternatively, thecontact member 12 can be formed from a single material, such as a metal or plastic material. - The
contact member 12 is dimensioned to a size consistent with that of a leaflet within a heart valve. For example, acontact member 12 approximating the size of a leaflet within an adult human mitral valve can have a width (indicated at W in FIG. 3) ranging from fifteen to fifty millimeters. Those skilled in the art will appreciate that the width of the contact member can vary according to the application. For example, in a heart valve sizing apparatus intended for use in children or small animals, a width smaller than fifteen millimeters may be appropriate. An apparatus intended for use in large animals, such as horses, might require a contact member with a width greater than fifty millimeters. - As shown in FIG. 2, a
longitudinal axis 26 extends longitudinally through theelongated member 16 substantially parallel to theaperture 22. While themember 16 is depicted as being substantially straight, it will be appreciated that it alternatively could be curved or formed a flexible material to facilitate curving the member. Thecontact surface 14 is curved in a convex manner relative to theaxis 26. Anotheraxis 28, shown in FIG. 3, is substantially perpendicular to theaxis 26 and coincides with the longest dimension (e.g., the width W) of thecontact member 12. Thecontact surface 14 is curved relative to thehorizontal axis 28 in a concave manner (e.g., curves away). As a result of this curvature, thecontact member 12 is configured to approximate a leaflet of a heart valve at closure of the valve. - The
proximal end 20 of theelongated member 16 can connect to a sleeve-like conduit interface 30, as depicted in FIG. 1. Theconduit interface 30 can be made from any durable, flexible material that is substantially biocompatible. Example materials include rubber or silicon, although other types of materials can also be used. Theproximal end 32 of theconduit interface 30 is adapted to connect to afluid source 34, which can include a syringe or other type of device capable of injecting fluid through theaperture 22. This adaptation allows theconduit interface 30 to fit tightly over anozzle 36 of thefluid source 34, while theother end 37 of the conduit interface connects to theproximal end 20 of theelongated member 16. Theconduit interface 30 thus can interconnect theelongated member 16 and thenozzle 36 to provide a substantially fluid-tight seal to enable the flow of fluids therethrough. - The
fluid source 34 contains a quantity of a fluid that can be passed through theaperture 22 of theelongated member 16. A number of fluids can be used, including air, water, saline, and blood to name a few. In the illustrated apparatus, the fluid source includes asyringe 38. Thesyringe 38 can be used to expel fluid from thefluid source 34 through thenozzle 36 and into theaperture 22 of theelongated member 16. One skilled the art will perceive other devices for controlling the flow of fluid from the fluid source, such as stop cocks and mechanical or electric pumps, and the use of these devices is intended to be encompassed within the claimed invention. Thefluid source 34 can be formed from a number of materials. For example, transparent materials, such as clear plastics and glass, can be used, as they allow a user to determine more easily the fluid level within thefluid source 34. - In view of various structural features of a sizing apparatus, in accordance with an aspect of the invention, use of such an apparatus to facilitate implantation of cardiac prosthesis will be better appreciated with reference to FIGS. 4-12. For example, as illustrated in FIGS. 4-7, implantation of a prosthesis can include the use of a
sizing tool 52 to ascertain an appropriate size for a prosthetic device in accordance with an aspect of the present invention. - In FIG. 4, the sizing
tool 52 has been inserted into aheart valve 54. Solely for the purpose of example, thevalve 54 is illustrated in FIGS. 4-12 as a mitral valve within a human heart, and the method is discussed in the context of implanting a prosthesis to replace the posterior leaflet within the mitral valve. One skilled in the art will appreciate, however, that the apparatus of the present invention may be used in other valves within the human heart, such as the tricuspid, pulmonary, or aortic valves, as well as in valves within animal hearts. Likewise, the present invention may be used to size a replacement for any leaflet, including the anterior leaflet of the mitral valve or the leaflets of any of the aforementioned valves. Such uses are intended to be encompassed in the appended claims. - The chamber above the
mitral valve 54 is theleft atrium 56 and the chamber below the valve is theleft ventricle 58. In FIG. 4, theanterior leaflet 60 is present and viable, but the posterior leaflet (not shown) is either nonviable or has been removed. Acontact member 62 of the sizingtool 52 is positioned at the position formerly occupied by the posterior leaflet, with acontact surface 64 facing theanterior leaflet 60. In accordance with one aspect of the present invention, thecontact member 62 can be positioned manually by a user holding anelongated handle 66 or other structure attached to the member. An inflow view of theopen valve 54 and sizingapparatus 52 is shown in FIG. 5. - The user would employ a
fluid source 68 in fluid communication with theapparatus 52 to supply fluid into theventricle 58. Such fluid thus flows through anaperture 70 within theelongated handle 66 into theleft ventricle 58. As discussed previously, this can be accomplished by a number of methods, such as a pump, syringe, or a stopcock. As the left ventricle fills 58 with fluid, theanterior leaflet 60 is urged toward its closed position and toward thecontact member 62. Depending on whether theapparatus 52 is an appropriate size, theanterior leaflet 60 can engage with thecontact member 62 to close the valve, as illustrated in FIG. 6. - Once the
anterior leaflet 60 has been urged into a closed position, the surgeon can examine the engagement between the anterior leaflet and thecontact member 62. Where theleaflet 60 and thecontact member 62 coapt, as to substantially prevent the flow of fluid through from the valve, a size of a corresponding prosthesis can be determined according to the size of thecontact member 62. An inflow view of aleaflet 60 coapting with acontact member 62 is illustrated in FIG. 7. When theleaflet 60 and thecontact member 62 coapt properly, the surgeon will know that a prosthetic device matching the size and shape of thecontact member 62 is appropriate for a prosthetic replacement. Where there is not sufficient coaptation between theleaflet 60 and thecontact member 62, a differently sized prosthesis should be used. - For example, where the
contact member 62 is too small to effectively coapt theleaflet 60, the surgeon may see small spaces or gaps between the leaflet and the contact member. This indicates a larger size prosthesis may be needed. This can be confirmed by repeating the sizing process with a larger sized contact member. - Where the
contact member 62 is too large, the annulus of thevalve 54 may distort, thereby preventing desired coaptation between thecontact member 62 and the leaflet. Additionally or alternatively, the orifice between thecontact member 62 and the leaflet may be considered be too small. A surgeon thus can readily ascertain that a prosthetic device matching the size of the contact member would be too large and seek a smaller device. - FIG. 8 illustrates an
apparatus 80 is provided where acontact member 82 can be made selectively detachable from anelongated member 84 In accordance with an aspect of the present invention. The selective attachment allows a surgeon to select from a number of alternate contact members of different size if theoriginal contact member 82 is too large or too small. By way of example, the distal end of theelongated member 84 can be threaded to allow a contact member to be screwed onto the elongated member. Those skilled in the art will appreciate other types of connections or fittings (e.g., friction fitting, snap fitting, and the like). - FIGS. 9 and 10 illustrate examples of alternative contact members,86 and 88. With the new contact member, the surgeon can repeat the sizing procedure described above to better approximate the size of an appropriate prosthetic leaflet. A desired one of the
contact members - FIG. 11 illustrates an example of a
cardiac prosthesis 100 that can be implanted according to the present method. For example, theprosthesis 100 can be of the type shown and described in U.S. patent application Ser. No. 10/215,800, filed on Aug. 4, 2002, to Gabbay, which is hereby incorporated by reference. - The
prosthesis 100 includes a generallyarcuate base portion 102 that can be closed or C-shaped. In accordance with an aspect of the present invention, a section of the base portion, indicated as a dottedportion 103, can be removable from the prosthesis 100 (e.g., by cutting) so that a surgeon can select the type of annulus desired—ring-like or C-shaped. Thebase portion 102 includes a support ring, which can be formed of a flexible, resilient, or generally rigid material. The support ring can have an elastic property that returns the ring to its original shape when deflected from its original (or rest) condition. The support ring, for example, can be a plastic-like material (e.g., a polymer, a resin, etc.) or a metal (e.g., stainless steel, a shape memory alloy, such as NITINOL), such as in the form of a wire. It will be understood and appreciated that other types of generally rigid, elastic, and/or resilient materials also can be used in accordance with the present invention. In addition, a suitable inelastically deformable material also could be used to form the support ring. - A
buttress 104 extends generally axially from anoutflow side 106 of thebase portion 102. Briefly stated, aproximal portion 108 of thebuttress 104 extends generally axially and radially inward from thebase portion 102. Adistally extending portion 110 of thebuttress 104 extends from theproximal portion 108 and curves radially outwardly therefrom for the remaining length of the buttress. Thebuttress 104 has a radiallyinner surface 112 that provides a surface against which a leaflet (e.g., an anterior leaflet of a mitral valve) can coapt at valve closure. - The
prosthesis 100, including thebuttress 104, can be selected according to the dimensions and configuration of a contact member from a sizing apparatus that has been determined to provide desired coaptation. Consequently, when theprosthesis 100 is implanted within a heart valve, a leaflet (or leaflets) can engage the buttress 104 to close the valve and provide substantially unidirectional flow of blood therethrough. The leaflet (or leaflets) is able to coapt with theinner surface 112 of thebuttress 104, thereby inhibiting regurgitation of blood when the ventricle contracts. - The
prosthesis 100 can also include anouter sheath 114 of a flexible, biocompatible material covering the apparatus. Theapparatus 100 also can include an implantation flange 116 (or sewing ring) that circumscribes thebase portion 102 of the apparatus. Theimplantation flange 116 extends radially outwardly from thebase portion 102 for facilitating implantation of theapparatus 100 at a heart valve. Each of theouter sheath 114 and theimplantation flange 116 can be formed of any suitable flexible, biocompatible material, such as a cloth-like or fabric (natural or synthetic) material or a biological material, such as collagen or an animal tissue material. An acceptable animal tissue material is smooth animal pericardium (e.g., equine, bovine, porcine, etc.), such as a NO-REACT® tissue product, which is available from Shelhigh, Inc. of Union, N.J. - Implantation of a cardiac prosthesis can be accomplished by several means. For the type of prosthesis illustrated in FIG. 11, these means will generally require open heart surgery. For example, the
base portion 102 can be sewn to the wall of thevalve 54 at theimplantation flange 116 to hold the prosthesis in place. Thebase portion 102 can also include barbs or hooks (not shown) that extend radially from the exterior of the base potion, such as disclosed in the above incorporated Gabbay patent application. These barbs can be pressed into the wall of the valve to directly engage the muscle tissue of the valve. - The implantation of other types of prostheses can be less invasive. For example, a prosthesis can be designed to be reducible to a smaller cross-sectional dimension for placement via a catheter or a type of implantation. The sizing tool and process used for these non-invasive techniques can vary from those described above, in accordance with additional aspects of the present invention.
- FIG. 12 illustrates a part of a heart in which a
prosthesis 130 is implanted at amitral valve 132. For the purpose of example, the implanted prosthesis will be the type ofprosthesis 100 illustrated in FIG. 11, but in which theremovable section 103 of theannular base 102 has been removed. It will be appreciated, however, that the present invention is not limited to use with this prosthesis. A number of other cardiac prostheses are available and suitable for use with the sizing apparatus of the present invention. - The
valve 132 facilitates a unidirectional flow of blood from theleft atrium 134 into theleft ventricle 136. Themitral valve 132 includes ananterior leaflet 138 that extends from the valve opening and attaches to muscular tissue in the wall of the left ventricle byfibrous cordae tendinae 140. A posterior leaflet (not shown) extends from an opposing surface of the valve opening and coapts the anterior leaflet at valve closure. In FIG. 12, the posterior leaflet has been substantially removed from the heart, such as by excising it before implanting theprosthesis 130. It is to be understood and appreciated, however, that the posterior leaflet can remain intact, with a buttress 142 of theprosthesis 130 interposed between the posterior and anterior leaflets. - The buttress142 extends from a base 144 of the
prosthesis 130 into theventricle 136 at a position corresponding to the position of the posterior leaflet of themitral valve 132. As mentioned above, thebuttress 142 extends into theventricle 136 It is to be appreciated that the buttress 142 can be formed of a generally rigid material that remains substantially stationary (e.g., static) during both the open and closed positions of the valve. Alternatively, the buttress 142 can be a sufficiently flexible- material to permit movement thereof commensurate with the flow of blood from theatrium 136 into theventricle 136 through thevalve 132. - FIG. 12 illustrates the
anterior leaflet 138 engaging the buttress 142 of theprosthesis 130, operating as a closed valve. In this way, the buttress 142 of theprosthesis 130 simulates the function of the posterior leaflet at valve closure by providing a surface against which theanterior leaflet 138 coapts. Consequently, the buttress 142 and theanterior leaflet 138 cooperate to inhibit regurgitation of blood from theleft ventricle 136 into theleft atrium 136, such as during ventricular contraction. - The buttress142, in conjunction with the
anterior leaflet 138, facilitates and promotes unidirectional flow of blood when the valve is open. In particular, when aprosthesis 130 of an appropriate size is implanted, an opening or aperture extends through the implantedprosthesis 130 between thebuttress 142 and theanterior leaflet 138. Advantageously, the movement of theanterior leaflet 138 relative to the buttress 142, in response to the flow of blood during the contraction of theleft atrium 136, provides a sufficient orifice to permit the substantially free flow of blood from the left atrium into theleft ventricle 136. The buttress 142 also can be formed of a flexible material that is able to move radially relative to the base portion 144 to further facilitate blood flow. - FIG. 13 illustrates an
apparatus 150 in accordance with another aspect of the invention. Theapparatus 150 includes acontact member 152. As is illustrated in FIG. 13, thecontact member 152 can be capable of assuming multiple configurations having different associated cross-sectional dimensions. The contact member has acurved surface 154 with an associated shape and area varying with the configuration of thecontact member 152. In the example of FIG. 13, the cross-sectional width dimension is shown to vary between W1 and W2, where W1>W2. In this way, a given apparatus can accommodate differently sized valves. Additionally, the positioning of the by contact member at the patient's heart valve can be facilitated when the contact member is at a reduced cross-section. In at least one configuration of thecontact member 152, thecurved surface 154 is shaped to engage a leaflet within a heart valve. - The
contact member 152 can be made from a material having with a natural shape and a tendency to return to that natural shape in the absence of a deforming force and the capacity to be deformed from that natural shape by pressure or some other means. By way of example, the contact member can be formed from a shape memory alloy material, such as Nitinol. Such an alloy can be formed into a particular shape and treated to allow it to “remember” that form. At low temperatures, the material remains pliant, but at higher temperatures, such as those within a patient's body, the material will attempt to revert to the remembered form. The shape memory alloy can be coated with natural or synthetic material, such as a soft plastic, rubber or biological material (e.g., animal pericardium, dura matter, etc.). - For example, the natural shape of the material corresponds to the configuration of the contact member having the largest cross-sectional dimension W1. It will be appreciated, however, that the apparatus may be designed such that the natural shape is the configuration with the smallest cross-sectional dimension W2 or an intermediate cross-sectional dimension, depending on the requirements of a given application.
- The illustrated
contact member 152 can be deformed into a configuration having a smaller cross-sectional dimension (e.g., less than W1) by one or more control members. In the illustrated embodiment, the control members include one or moreelongated restraints - The restraints are connected at their distal ends to the
lateral edges contact member 152 to hold the contact member in a configuration having a reduced cross-sectional dimension. Anelongated member 159 extends from thecontact member 152 to a proximal end (not shown). One or more apertures (also not shown) extend through theelongated member 159 from itsproximal end 162 to a point near thecontact surface 154 of thecontact member 152. Therestraints more orifices elongated member 159 at a point near thecontact surface 154. Therestraints proximal end 162 of theelongated member 160. At the proximal end, therestraints restraints contact member 152. - The configuration of the
contact member 152 can be controlled by the control device at the proximal end of theelongated member 159. The control device is operative to increase or decrease the length of therestraints proximal end 162 of theelongated member 159 and thelateral edges contact member 152. As the portion of therestraints proximal end 162 and thelateral edges contact member 152 is shortened, the restraints operate to pull the lateral edges closer together, reducing the cross-sectional dimension of the contact member (e.g., to less than W1). When the tension on therestraints apertures lateral edges contact member 152 attempting to return to its natural configuration (e.g., W1). The expanded size thus will vary according to the length of the restraints between theapertures lateral edges - It will be appreciated that the control device can include any of a number of devices useful in controlling the tension on the
restraints restraints - Regardless of the specific control device used, markings or indicia can be provided on the device, for example, on the device exterior, to directly or indirectly measure the length of the
restraints proximal end 162 and thelateral edges contact member 152. Theapparatus 150 can be calibrated such that a particular length of one or more of therestraints contact member 152, allowing the cross-sectional dimension to be determined from the measurement of the length of the one or more restraints. - An intended purpose of the
apparatus 150 of FIG. 13 is its use in a minimally invasive sizing process to precede implantation of a valvuloplasty device, such as shown and described in the above-incorporated Gabbay patent application. The illustratedcontact member 152 can be deformed to a configuration having a reduced cross-sectional dimension to facilitate placement of the device. Theapparatus 150 can be mounted to a catheter, an elongated handle, or another positioning device for insertion into a heart valve. An appropriate vision system can be included with theapparatus 150 to guide the placement of theapparatus 150 and determine if a particular configuration of the contact member provides effective coaptation with any viable leaflets in the valve. - Where the
apparatus 150 is mounted to an elongated handle, a low invasive minithoracotomy can be used to gain access to the heart of the patient and theapparatus 150 can be inserted through the minithoracotomy passage. Thecontact member 152 is first placed into a configuration having a minimal cross-sectional dimension. The surgeon can then guide theapparatus 150 through the passage using an appropriate vision system to bring thecontact member 152 into a desired position for engaging with any viable leaflets of the valve. The cross-sectional dimension of the contact member can then be expanded to the size where it engages with the viable leaflets and the cross-sectional dimension necessary to provide effective coaptation can be recorded. The point where effective coaptation takes place can be determined by the surgeon using the vision system. The cross-sectional dimension of thecontact member 152 can then be reduced back to its initial, minimal configuration to facilitate withdrawal of the device. It will be appreciated that such a procedure can be implemented with little or no cardiopulmonary bypass. - Similarly, where the
apparatus 150 is mounted to a catheter, it can be inserted into the heart valve from a remote entry point within the body. When a catheter is used to position theapparatus 150, an electromechanical mechanism can be used to adjust the length of therestraints contact member 152, as therestraints contact member 152 can be reduced to facilitate passage through blood vessels into the valve, and expanded to measure the size of a prosthetic replacement necessary to provide effective coaptation of any viable leaflets. The cross-sectional dimension of thecontact member 152 can then be reduced to allow theapparatus 150 to be removed. - FIG. 14 illustrates an
apparatus 210 in accordance with another aspect of the invention. Theapparatus 210 includes acontact member 212. As is illustrated in FIG. 14, thecontact member 212 is capable of assuming a plurality (e.g., at least two) configurations, each having a different associated cross-sectional dimension. Two such dimensions are depicted at W1 and W2, where W1>W2. Thecontact member 212 has acurved surface 214 with an associated shape and area varying with the configuration of thecontact member 212. Thesize contact member 212 thus is variable to accommodate differently sized heart valves. Additionally, the contact member can be provided in a sufficiently reduce cross-sectional dimension to facilitate its positioning at a patient's heart valve by minimally invasive means according to an aspect of the present invention. - The contact member212 (or at least the
surface 214 thereof) is formed from a fluidimpermeable membrane 241 defining an interior chamber. Theouter membrane 241 can be formed from rubber, flexible plastic, or any other elastic, fluid-impermeable substance that is substantially biocompatible. The interior chamber of themember 212 is connected to a fluid source (not shown) that can be located near the proximal end of theelongated member 244 through aconduit 245 or other fluid communicating member. Theconduit 245, for example, can be formed as an aperture extending through theelongated member 244. - A control device (not shown) on the fluid source directs a fluid through the
aperture 245 to the interior chamber. This mechanism can be a pump, a syringe, a bellows, or any similar device for encouraging the flow of fluid. The fluid itself may be air, water, saline, blood, or any other biocompatible fluid. As the interior chamber fills with fluid, it inflates theouter membrane 241 causing thecontact member 212 to assume a configuration having a cross-sectional dimension functionally related to the amount of fluid in the chamber of themember 212. The cross-sectional dimension of thecontact member 212 can be ascertained according to the amount of fluid that is directed into the interior chamber. Theapparatus 210 can be calibrated such that a particular fluid level can be translated into an appropriate cross-sectional dimension. A control device can include means for evacuating the fluid within the interior chamber, either back into the fluid source, or into the heart valve. - An intended purpose of the
apparatus 210 illustrated in FIG. 14 is its use in a minimally invasive sizing process to precede implantation of a valvuloplasty device. In this process, thecontact member 212 begins with theouter membrane 241 deflated to provide a reduced cross-sectional dimension that facilitates placement of the device. Theapparatus 210 can be mounted to a catheter, an elongated handle, or another positioning device for insertion into a heart valve. The fluid source can connect to thecontact member 212 through anaperture 246 in theelongated member 244. An appropriate vision system can be included with the device to guide the placement of the device and determine if a particular configuration of thecontact member 212 provides effective coaptation with any viable leaflets in the valve. - Where the
apparatus 210 is mounted to an elongated handle, a low invasive minithoracotomy can be used to gain access to the heart of the patient, such that theapparatus 210 can be inserted through the minithoracotomy passage. Thecontact member 212 is placed in a deflated configuration having a minimal cross-sectional dimension to facilitate positioning of the device. The surgeon can then guide theapparatus 210 through the passage using an appropriate vision system to place thecontact member 212 at a desired position for engaging one or more viable leaflets of the valve. The cross-sectional dimension of thecontact member 212 can then be selectively expanded through inflation of theouter membrane 241 to the point where the viable leaflets can engage thesurface 214 to inhibit flow of fluid through the valve annulus (e.g., simulating operation of competent heart valve). The cross-sectional dimension necessary to provide effective coaptation can be recorded based on the amount of fluid provided to the inner chamber, for example. The coaptation between the contact member and the valve leaflet (or leaflets) can be determined by the surgeon using the vision system. The cross-sectional dimension of thecontact member 212 can then be reduced back to its initial, minimal configuration to facilitate withdrawal of the device by evacuating the fluid within the device. It will be appreciated that such a procedure can be implemented with little or no cardiopulmonary bypass. - Similarly, the
apparatus 210 can be mounted to a catheter for insertion into the heart valve from a remote entry point of the body. When a catheter is used to position theapparatus 210, a separate tube can be included to carry fluid to the interior chamber from the fluid source to adjust the configuration of thecontact member 212. The cross-sectional dimension of thecontact member 212 is placed in a reduced form to facilitate passage through blood vessels into the valve. The inner chamber of thecontact member 212 is then filled at least partially with fluid to expand thecontact member 212 to determine a suitable size of a prosthetic device to provide effective coaptation of any viable leaflets. The cross-sectional dimension of thecontact member 212 can then be reduced to allow theapparatus 210 to be removed by evacuating the fluid from the inner chamber. - In view of the foregoing, an apparatus according to the present invention provides a useful apparatus for determining the necessary size for a valvuloplasty device intended for implantation into a heart valve. A method for utilizing the apparatus for sizing a heart valve has been described. Embodiments of the apparatus that are useful for a minimally invasive sizing procedure have been provided.
- What has been described above are examples of the present invention. It is, of course, not possible to describe every conceivable combination of components or methodologies for purposes of describing the present invention, but one of ordinary skill in the art will recognize that many further combinations and permutations of the present invention are possible. For example, while many of the illustrated examples show the discuss the treatment of a bicuspid (mitral) valve, an apparatus in accordance with the present invention can also be useful in sizing prosthetic devices for other types of heart valves (e.g., a tricuspid valve or other bicuspid valves). Accordingly, the present invention is intended to embrace all such alterations, modifications and variations that fall within the spirit and scope of the appended claims. Furthermore, to the extent that the term “includes” is used in either the detailed description or the claims, such term is intended to be inclusive in a manner similar to the term “comprising.”
Claims (24)
1. A sizing apparatus for a prosthetic device, comprising:
a contact member having a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve; and
an elongated member extending from the contact member and terminating in a proximal end.
2. The sizing apparatus of claim 1 , further comprising an aperture extending through the elongated member from the proximal end and terminating in an opening end near the contact member to facilitate flow of fluid therethrough.
3. The sizing apparatus of claim 2 , the aperture terminating near a surface of the contact member opposite the curved surface.
4. The sizing apparatus of claim 2 , further comprising a fluid source operative to supply fluid into the aperture.
5. The sizing apparatus of claim 4 , the fluid source further comprising a syringe for providing fluid into the aperture.
6. The sizing apparatus of claim 4 , further comprising a conduit interface that extends from the proximal end of the elongated member and terminates in a proximal end portion thereof, the proximal end portion of the conduit interface being adapted to connect to the fluid source.
7. The sizing apparatus of claim 6 , the conduit interface further comprising a flexible material.
8. The sizing apparatus of claim 1 , the contact member having a first axis substantially parallel with the elongated member and a second axis substantially perpendicular with the elongated member, the contact member being curved along at least one of the first and second axes.
9. The sizing apparatus of claim 1 , the contact member being dimensioned and configured to approximate a radially inner surface of at least one leaflet at closure.
10. The sizing apparatus of claim 1 , the contact member being configured to provide a cross-sectional dimension that is variable between a reduced cross-sectional dimension to facilitate positioning thereof at the heart valve and an expanded cross-sectional dimension to facilitate determining the size of a desired cardiac prosthesis based on engagement between the contact member and the at least one leaflet.
11. The sizing apparatus of claim 10 , the contact member further comprising a fluid impermeable outer membrane having an inner chamber, the outer membrane defining the cross-sectional dimension of the contact member based on an amount of fluid within the inner chamber.
12. The sizing apparatus of claim 10 , further comprising a control member operative to adjust the cross-sectional dimension of the contact member to a desired size.
13. The sizing apparatus of claim 10 , further comprising a retaining mechanism operative to adjust the cross-sectional dimension of the contact member to a desired size, the contact member being self-expanding from the reduced cross-sectional dimension to the expanded cross-sectional dimension.
14. The sizing apparatus of claim 13 , the retaining mechanism further comprising at least one elongated elements having distal ends connected to lateral edges of the contact member and proximal ends that extend from the contact member, the cross-sectional dimension of the contact member, varying as a function of the length of at least one of the connecting elements between the proximal end of the elongated member and the respective lateral edge of the contact member to which the at least one connecting element is connected.
15. The sizing apparatus of claim 10 , the contact member comprising a material having shape memory properties so that the contact member is self-expanding from the reduced cross-sectional dimension to the expanded cross-sectional dimension.
16. An apparatus for determining an appropriate size for a prosthetic device, comprising:
means for contacting at least one leaflet of a patient's heart valve, such that the amount of coaptation between the at least one leaflet and the means for contacting is indicative of sizing requirements for a cardiac prosthesis; and
means to facilitate positioning the means for contacting to an appropriate position relative to the at least one leaflet of the patient's heart valve, the means for positioning extending from the means for contacting.
17. An apparatus as set forth in claim 16 , including means for urging the at least one viable leaflet toward the means for contacting.
18. A sizing apparatus for a prosthetic device, comprising:
a contact member having a curved surface that is configured to be engaged by at least one functioning leaflet of a heart valve within a patient when the contact member is positioned at the heart valve;
an elongated member extending from the contact member and terminating in a proximal end; and
an aperture extending through the elongated member from the proximal end and terminating in an opening end proximal the contact member to facilitate flow of fluid therethrough.
19. A method to facilitate selecting a cardiac prosthesis for implantation at a patient's heart valve, the method comprising:
positioning a contact member to an appropriate position relative to at least one leaflet of the patient's heart valve;
urging the at least one leaflet of a patient's heart valve toward the contact member, the contact member having a known cross-sectional dimension; and
determining sizing requirements for the cardiac prosthesis based on coaptation between the at least one leaflet and the contact member.
20. The method of claim 19 , further comprising:
selecting a cardiac prosthesis based on the determined sizing requirements, the cardiac prosthesis comprising a generally arcuate base and a buttress extending from the base; and
implanting the cardiac prosthesis at the patient's heart valve such that the at least one leaflet is moveable relative to the buttress to provide substantially unidirectional flow of blood through the heart valve.
21. The method of claim 19 , wherein the contact member is a first contact member and the method further includes positioning a second contact member having a different cross-sectional dimension than that of the first contact member in place of the first contact member.
22. The method of claim 19 , further comprising adjusting the cross-sectional dimension of the contact member.
23. The method of claim 22 , wherein the adjusting of the cross-sectional dimension of the contact member includes one of supplying and removing fluid from within the contact member.
24. The method of claim 22 , wherein the contact member is self-expanding from a reduced cross-sectional dimension to an expanded cross-sectional dimension, and the adjusting of the cross-sectional dimension of the contact member includes adjusting a length of at least one retaining mechanism that is operatively connected to the contact member.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/396,656 US20040193259A1 (en) | 2003-03-25 | 2003-03-25 | Sizing apparatus for cardiac prostheses and method of using same |
US11/132,059 US7357814B2 (en) | 2003-03-25 | 2005-05-18 | Method of determining size of cardiac prosthesis |
US11/214,104 US7510573B2 (en) | 2003-03-25 | 2005-08-29 | Sizing apparatus |
PCT/US2006/029955 WO2007027349A2 (en) | 2003-03-25 | 2006-07-31 | Sizing apparatus |
CA002608860A CA2608860A1 (en) | 2003-03-25 | 2006-07-31 | Sizing apparatus |
EP06800617A EP1919399A4 (en) | 2003-03-25 | 2006-07-31 | Sizing apparatus |
JP2008529044A JP2009505785A (en) | 2003-03-25 | 2006-07-31 | Dimension setting device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/396,656 US20040193259A1 (en) | 2003-03-25 | 2003-03-25 | Sizing apparatus for cardiac prostheses and method of using same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/132,059 Division US7357814B2 (en) | 2003-03-25 | 2005-05-18 | Method of determining size of cardiac prosthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040193259A1 true US20040193259A1 (en) | 2004-09-30 |
Family
ID=32988817
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/396,656 Abandoned US20040193259A1 (en) | 2003-03-25 | 2003-03-25 | Sizing apparatus for cardiac prostheses and method of using same |
US11/132,059 Expired - Fee Related US7357814B2 (en) | 2003-03-25 | 2005-05-18 | Method of determining size of cardiac prosthesis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/132,059 Expired - Fee Related US7357814B2 (en) | 2003-03-25 | 2005-05-18 | Method of determining size of cardiac prosthesis |
Country Status (1)
Country | Link |
---|---|
US (2) | US20040193259A1 (en) |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040171932A1 (en) * | 2002-11-27 | 2004-09-02 | Raghav Raman | Quantification of aortoiliac endoluminal irregularity |
US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US20050180621A1 (en) * | 2002-11-27 | 2005-08-18 | Raghav Raman | Quantification of vascular irregularity |
US20060058871A1 (en) * | 2004-09-14 | 2006-03-16 | Edwards Lifesciences, Ag | Device and method for treatment of heart valve regurgitation |
US20060241745A1 (en) * | 2005-04-21 | 2006-10-26 | Solem Jan O | Blood flow controlling apparatus |
US20070250160A1 (en) * | 2006-04-21 | 2007-10-25 | Medtronic Vascular, Inc. | Device, system, and method for treating cardiac valve regurgitation |
US20070282429A1 (en) * | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
EP1919399A2 (en) * | 2003-03-25 | 2008-05-14 | Shlomo Gabbay | Sizing apparatus |
US20080262603A1 (en) * | 2007-04-23 | 2008-10-23 | Sorin Biomedica Cardio | Prosthetic heart valve holder |
US20090018570A1 (en) * | 2007-07-12 | 2009-01-15 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve crimping device |
US20090292353A1 (en) * | 2005-12-15 | 2009-11-26 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US20100023117A1 (en) * | 2005-12-15 | 2010-01-28 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems, & methods |
US7722643B2 (en) | 1999-03-01 | 2010-05-25 | Medtronic, Inc. | Tissue connector apparatus and methods |
US7744611B2 (en) | 2000-10-10 | 2010-06-29 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US7763040B2 (en) | 1998-06-03 | 2010-07-27 | Medtronic, Inc. | Tissue connector apparatus and methods |
US20100249661A1 (en) * | 2009-03-19 | 2010-09-30 | Sorin Biomedica Cardio S.r.I | Universal Valve Annulus Sizing Device |
US20100262043A1 (en) * | 2009-03-26 | 2010-10-14 | Sorin Group Usa, Inc. | Annuloplasty sizers for minimally invasive procedures |
US7879047B2 (en) | 2003-12-10 | 2011-02-01 | Medtronic, Inc. | Surgical connection apparatus and methods |
US7896892B2 (en) | 2000-03-31 | 2011-03-01 | Medtronic, Inc. | Multiple bias surgical fastener |
US20110071622A1 (en) * | 2009-09-23 | 2011-03-24 | Fehling Instruments Gmbh & Co. Kg | Instrument for the surgical treatment of aortic valve defects |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US7938840B2 (en) | 1999-04-05 | 2011-05-10 | Medtronic, Inc. | Apparatus and methods for anastomosis |
US7963973B2 (en) | 1998-06-03 | 2011-06-21 | Medtronic, Inc. | Multiple loop tissue connector apparatus and methods |
US7972376B1 (en) | 2007-12-21 | 2011-07-05 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US7976556B2 (en) | 2002-09-12 | 2011-07-12 | Medtronic, Inc. | Anastomosis apparatus and methods |
US8007992B2 (en) | 2006-10-27 | 2011-08-30 | Edwards Lifesciences Corporation | Method of treating glutaraldehyde-fixed pericardial tissue with a non-aqueous mixture of glycerol and a C1-C3 alcohol |
US8029519B2 (en) | 2003-08-22 | 2011-10-04 | Medtronic, Inc. | Eversion apparatus and methods |
US8057396B2 (en) | 2006-05-24 | 2011-11-15 | Phoenix Biomedical, Inc. | Device for assessing a cardiac valve |
US8105345B2 (en) | 2002-10-04 | 2012-01-31 | Medtronic, Inc. | Anastomosis apparatus and methods |
US8118822B2 (en) | 1999-03-01 | 2012-02-21 | Medtronic, Inc. | Bridge clip tissue connector apparatus and methods |
US8177836B2 (en) | 2008-03-10 | 2012-05-15 | Medtronic, Inc. | Apparatus and methods for minimally invasive valve repair |
US8211124B2 (en) | 2003-07-25 | 2012-07-03 | Medtronic, Inc. | Sealing clip, delivery systems, and methods |
US8236241B2 (en) | 1998-09-21 | 2012-08-07 | Edwards Lifesciences Corporation | Treating biological tissues to mitigate post-implantation calcification |
US8394114B2 (en) | 2003-09-26 | 2013-03-12 | Medtronic, Inc. | Surgical connection apparatus and methods |
US8518060B2 (en) | 2009-04-09 | 2013-08-27 | Medtronic, Inc. | Medical clip with radial tines, system and method of using same |
US8529583B1 (en) | 1999-09-03 | 2013-09-10 | Medtronic, Inc. | Surgical clip removal apparatus |
US8632608B2 (en) | 2002-01-03 | 2014-01-21 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US8668704B2 (en) | 2009-04-24 | 2014-03-11 | Medtronic, Inc. | Medical clip with tines, system and method of using same |
US8846390B2 (en) | 2010-03-23 | 2014-09-30 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US8906601B2 (en) | 2010-06-17 | 2014-12-09 | Edwardss Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US9101691B2 (en) | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US20150351911A1 (en) * | 2013-01-25 | 2015-12-10 | Medtentia International Ltd Oy | A Medical Device And Method For Facilitating Selection Of An Annuloplasty Implant |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9351829B2 (en) | 2010-11-17 | 2016-05-31 | Edwards Lifesciences Corporation | Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability |
US9486313B2 (en) | 2005-02-10 | 2016-11-08 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US10085835B2 (en) | 2004-03-11 | 2018-10-02 | Percutaneous Cardiovascular Solutions Pty Ltd | Percutaneous heart valve prosthesis |
US10098733B2 (en) | 2008-12-23 | 2018-10-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US10166014B2 (en) | 2008-11-21 | 2019-01-01 | Percutaneous Cardiovascular Solutions Pty Ltd | Heart valve prosthesis and method |
US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US10952846B2 (en) | 2008-05-01 | 2021-03-23 | Edwards Lifesciences Corporation | Method of replacing mitral valve |
US11478351B2 (en) | 2018-01-22 | 2022-10-25 | Edwards Lifesciences Corporation | Heart shape preserving anchor |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11819406B2 (en) | 2018-05-23 | 2023-11-21 | Corcym S.R.L. | Loading system for an implantable prosthesis and related loading method |
US11992397B2 (en) | 2018-05-23 | 2024-05-28 | Corcym S.R.L. | Holder for heart valve prosthesis, a storage arrangement for a heart valve prosthesis, and a crimping kit and method |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7462156B2 (en) * | 2005-04-11 | 2008-12-09 | Zan Mitrev | Replacement aortic valve leaflets and related technology |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
WO2015195823A1 (en) | 2014-06-18 | 2015-12-23 | Middle Peak Medical, Inc. | Mitral valve implants for the treatment of valvular regurgitation |
ES2914153T3 (en) | 2014-06-24 | 2022-06-07 | Polares Medical Inc | Systems to anchor an implant |
US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10514436B2 (en) * | 2017-03-03 | 2019-12-24 | Rohde & Schwarz Gmbh & Co. Kg | Test device, remote measurement module and test method |
US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN115040289A (en) | 2017-03-13 | 2022-09-13 | 宝来瑞斯医疗有限公司 | Devices, systems, and methods for transcatheter treatment of valve regurgitation |
US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US20210196462A1 (en) * | 2019-12-31 | 2021-07-01 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1488463A (en) * | 1921-11-17 | 1924-04-01 | Abram Edmund William | Combination table utensil |
US1767659A (en) * | 1928-05-04 | 1930-06-24 | Ferguson William | Sheet-metal bumping-out tool |
US4042979A (en) * | 1976-07-12 | 1977-08-23 | Angell William W | Valvuloplasty ring and prosthetic method |
US4240161A (en) * | 1979-02-21 | 1980-12-23 | Medical, Incorporated | Arcuate disc heart valve |
US4350492A (en) * | 1981-08-24 | 1982-09-21 | Vascor, Inc. | Method for preparing tissue heart valve |
US4491986A (en) * | 1976-05-12 | 1985-01-08 | Shlomo Gabbay | Heart valve |
US4759758A (en) * | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US5258021A (en) * | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
US5549665A (en) * | 1993-06-18 | 1996-08-27 | London Health Association | Bioprostethic valve |
US5584879A (en) * | 1993-12-13 | 1996-12-17 | Brigham & Women's Hospital | Aortic valve supporting device |
US5800527A (en) * | 1992-07-10 | 1998-09-01 | Adiam Medizintechnik Gmbh & Co. Kg | Support housing for valve and closure members, in particular for heart valve prostheses |
US5861028A (en) * | 1996-09-09 | 1999-01-19 | Shelhigh Inc | Natural tissue heart valve and stent prosthesis and method for making the same |
US6110200A (en) * | 1995-06-07 | 2000-08-29 | St. Jude Medical, Inc. | Adjustable sizing apparatus |
US6129758A (en) * | 1995-10-06 | 2000-10-10 | Cardiomend Llc | Products and methods for circulatory system valve repair |
US6350281B1 (en) * | 1999-09-14 | 2002-02-26 | Edwards Lifesciences Corp. | Methods and apparatus for measuring valve annuluses during heart valve-replacement surgery |
US20020103531A1 (en) * | 1999-01-26 | 2002-08-01 | Robert Stobie | Combination anatomical orifice sizer and heart valve |
US6517576B2 (en) * | 2000-12-11 | 2003-02-11 | Shlomo Gabbay | Implantable patch prosthesis having one or more cusps for improved competency |
US20030069586A1 (en) * | 2001-07-16 | 2003-04-10 | Errico Joseph P. | Instrumentation and methods for use in implanting an artificial intervertebral disc |
US20030078651A1 (en) * | 2001-05-17 | 2003-04-24 | Schoon Thomas G. | Aortic heart valve prosthesis implantation tool |
US6598307B2 (en) * | 1999-11-17 | 2003-07-29 | Jack W. Love | Device and method for assessing the geometry of a heart valve |
US6613085B1 (en) * | 1996-01-31 | 2003-09-02 | St. Jude Medical, Inc. | Prosthetic heart valve rotator tool |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19745847C1 (en) | 1997-07-14 | 1998-08-13 | Paul Dr Med Krueger | Medical instrument for acnetherapy |
US6678962B1 (en) * | 1999-11-17 | 2004-01-20 | Cardiomend Llc | Device and method for assessing the geometry of a heart valve |
US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
US6869444B2 (en) * | 2000-05-22 | 2005-03-22 | Shlomo Gabbay | Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve |
-
2003
- 2003-03-25 US US10/396,656 patent/US20040193259A1/en not_active Abandoned
-
2005
- 2005-05-18 US US11/132,059 patent/US7357814B2/en not_active Expired - Fee Related
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1488463A (en) * | 1921-11-17 | 1924-04-01 | Abram Edmund William | Combination table utensil |
US1767659A (en) * | 1928-05-04 | 1930-06-24 | Ferguson William | Sheet-metal bumping-out tool |
US4491986A (en) * | 1976-05-12 | 1985-01-08 | Shlomo Gabbay | Heart valve |
US4042979A (en) * | 1976-07-12 | 1977-08-23 | Angell William W | Valvuloplasty ring and prosthetic method |
US4240161A (en) * | 1979-02-21 | 1980-12-23 | Medical, Incorporated | Arcuate disc heart valve |
US4350492A (en) * | 1981-08-24 | 1982-09-21 | Vascor, Inc. | Method for preparing tissue heart valve |
US4759758A (en) * | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US5258021A (en) * | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
US5800527A (en) * | 1992-07-10 | 1998-09-01 | Adiam Medizintechnik Gmbh & Co. Kg | Support housing for valve and closure members, in particular for heart valve prostheses |
US5549665A (en) * | 1993-06-18 | 1996-08-27 | London Health Association | Bioprostethic valve |
US5584879A (en) * | 1993-12-13 | 1996-12-17 | Brigham & Women's Hospital | Aortic valve supporting device |
US6110200A (en) * | 1995-06-07 | 2000-08-29 | St. Jude Medical, Inc. | Adjustable sizing apparatus |
US6129758A (en) * | 1995-10-06 | 2000-10-10 | Cardiomend Llc | Products and methods for circulatory system valve repair |
US6613085B1 (en) * | 1996-01-31 | 2003-09-02 | St. Jude Medical, Inc. | Prosthetic heart valve rotator tool |
US5861028A (en) * | 1996-09-09 | 1999-01-19 | Shelhigh Inc | Natural tissue heart valve and stent prosthesis and method for making the same |
US20020103531A1 (en) * | 1999-01-26 | 2002-08-01 | Robert Stobie | Combination anatomical orifice sizer and heart valve |
US6350281B1 (en) * | 1999-09-14 | 2002-02-26 | Edwards Lifesciences Corp. | Methods and apparatus for measuring valve annuluses during heart valve-replacement surgery |
US6598307B2 (en) * | 1999-11-17 | 2003-07-29 | Jack W. Love | Device and method for assessing the geometry of a heart valve |
US6517576B2 (en) * | 2000-12-11 | 2003-02-11 | Shlomo Gabbay | Implantable patch prosthesis having one or more cusps for improved competency |
US20030078651A1 (en) * | 2001-05-17 | 2003-04-24 | Schoon Thomas G. | Aortic heart valve prosthesis implantation tool |
US6719785B2 (en) * | 2001-05-17 | 2004-04-13 | St. Jude Medical, Inc. | Aortic heart valve prosthesis implantation tool |
US20030069586A1 (en) * | 2001-07-16 | 2003-04-10 | Errico Joseph P. | Instrumentation and methods for use in implanting an artificial intervertebral disc |
Cited By (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763040B2 (en) | 1998-06-03 | 2010-07-27 | Medtronic, Inc. | Tissue connector apparatus and methods |
US7963973B2 (en) | 1998-06-03 | 2011-06-21 | Medtronic, Inc. | Multiple loop tissue connector apparatus and methods |
US8236241B2 (en) | 1998-09-21 | 2012-08-07 | Edwards Lifesciences Corporation | Treating biological tissues to mitigate post-implantation calcification |
US8118822B2 (en) | 1999-03-01 | 2012-02-21 | Medtronic, Inc. | Bridge clip tissue connector apparatus and methods |
US7892255B2 (en) | 1999-03-01 | 2011-02-22 | Medtronic, Inc. | Tissue connector apparatus and methods |
US8353921B2 (en) | 1999-03-01 | 2013-01-15 | Medtronic, Inc | Tissue connector apparatus and methods |
US7722643B2 (en) | 1999-03-01 | 2010-05-25 | Medtronic, Inc. | Tissue connector apparatus and methods |
US8211131B2 (en) | 1999-04-05 | 2012-07-03 | Medtronic, Inc. | Apparatus and methods for anastomosis |
US7938840B2 (en) | 1999-04-05 | 2011-05-10 | Medtronic, Inc. | Apparatus and methods for anastomosis |
US8529583B1 (en) | 1999-09-03 | 2013-09-10 | Medtronic, Inc. | Surgical clip removal apparatus |
US8353092B2 (en) | 2000-03-31 | 2013-01-15 | Medtronic, Inc. | Multiple bias surgical fastener |
US7896892B2 (en) | 2000-03-31 | 2011-03-01 | Medtronic, Inc. | Multiple bias surgical fastener |
US7914544B2 (en) | 2000-10-10 | 2011-03-29 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US7744611B2 (en) | 2000-10-10 | 2010-06-29 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US8632608B2 (en) | 2002-01-03 | 2014-01-21 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US8066724B2 (en) | 2002-09-12 | 2011-11-29 | Medtronic, Inc. | Anastomosis apparatus and methods |
US7976556B2 (en) | 2002-09-12 | 2011-07-12 | Medtronic, Inc. | Anastomosis apparatus and methods |
US8298251B2 (en) | 2002-10-04 | 2012-10-30 | Medtronic, Inc. | Anastomosis apparatus and methods |
US8105345B2 (en) | 2002-10-04 | 2012-01-31 | Medtronic, Inc. | Anastomosis apparatus and methods |
US20040171932A1 (en) * | 2002-11-27 | 2004-09-02 | Raghav Raman | Quantification of aortoiliac endoluminal irregularity |
US7379574B2 (en) * | 2002-11-27 | 2008-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Quantification of vascular irregularity |
US20050180621A1 (en) * | 2002-11-27 | 2005-08-18 | Raghav Raman | Quantification of vascular irregularity |
US7324675B2 (en) * | 2002-11-27 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Quantification of aortoiliac endoluminal irregularity |
EP1919399A4 (en) * | 2003-03-25 | 2010-06-23 | Shlomo Gabbay | Sizing apparatus |
EP1919399A2 (en) * | 2003-03-25 | 2008-05-14 | Shlomo Gabbay | Sizing apparatus |
JP2009505785A (en) * | 2003-03-25 | 2009-02-12 | シュロモ・ギャバイ | Dimension setting device |
US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US8211124B2 (en) | 2003-07-25 | 2012-07-03 | Medtronic, Inc. | Sealing clip, delivery systems, and methods |
US8029519B2 (en) | 2003-08-22 | 2011-10-04 | Medtronic, Inc. | Eversion apparatus and methods |
US8394114B2 (en) | 2003-09-26 | 2013-03-12 | Medtronic, Inc. | Surgical connection apparatus and methods |
US7879047B2 (en) | 2003-12-10 | 2011-02-01 | Medtronic, Inc. | Surgical connection apparatus and methods |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US10085835B2 (en) | 2004-03-11 | 2018-10-02 | Percutaneous Cardiovascular Solutions Pty Ltd | Percutaneous heart valve prosthesis |
US20100198347A1 (en) * | 2004-09-14 | 2010-08-05 | Edwards Lifesciences Ag | Device and method for treatment of heart valve regurgitation |
US20060058871A1 (en) * | 2004-09-14 | 2006-03-16 | Edwards Lifesciences, Ag | Device and method for treatment of heart valve regurgitation |
US7704277B2 (en) | 2004-09-14 | 2010-04-27 | Edwards Lifesciences Ag | Device and method for treatment of heart valve regurgitation |
US8460370B2 (en) | 2004-09-14 | 2013-06-11 | Edwards Lifesciences Ag | Device and method for treatment of heart valve regurgitation |
US8992605B2 (en) | 2004-09-14 | 2015-03-31 | Edwards Lifesciences Ag | Device and method for reducing mitral valve regurgitation |
US9486313B2 (en) | 2005-02-10 | 2016-11-08 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9895223B2 (en) | 2005-02-10 | 2018-02-20 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US11033389B2 (en) | 2005-04-21 | 2021-06-15 | Edwards Lifesciences Ag | Method for replacing a heart valve |
US20060241745A1 (en) * | 2005-04-21 | 2006-10-26 | Solem Jan O | Blood flow controlling apparatus |
US10039531B2 (en) * | 2005-12-15 | 2018-08-07 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US20090292353A1 (en) * | 2005-12-15 | 2009-11-26 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US20100023117A1 (en) * | 2005-12-15 | 2010-01-28 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems, & methods |
US9125742B2 (en) * | 2005-12-15 | 2015-09-08 | Georgia Tech Research Foundation | Papillary muscle position control devices, systems, and methods |
US20070250160A1 (en) * | 2006-04-21 | 2007-10-25 | Medtronic Vascular, Inc. | Device, system, and method for treating cardiac valve regurgitation |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US11141272B2 (en) | 2006-05-18 | 2021-10-12 | Edwards Lifesciences Ag | Methods for improving heart valve function |
US10213305B2 (en) | 2006-05-18 | 2019-02-26 | Edwards Lifesciences Ag | Device and method for improving heart valve function |
US9827101B2 (en) | 2006-05-18 | 2017-11-28 | Edwards Lifesciences Ag | Device and method for improving heart valve function |
US8057396B2 (en) | 2006-05-24 | 2011-11-15 | Phoenix Biomedical, Inc. | Device for assessing a cardiac valve |
US8585594B2 (en) | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
US9579199B2 (en) | 2006-06-01 | 2017-02-28 | Edwards Lifesciences Corporation | Method for treating a mitral valve |
US11839545B2 (en) | 2006-06-01 | 2023-12-12 | Edwards Lifesciences Corporation | Method of treating a defective heart valve |
US10583009B2 (en) | 2006-06-01 | 2020-03-10 | Edwards Lifesciences Corporation | Mitral valve prosthesis |
US10799361B2 (en) | 2006-06-01 | 2020-10-13 | Edwards Lifesciences Corporation | Method of treating a defective mitral valve by filling gap |
US10441423B2 (en) | 2006-06-01 | 2019-10-15 | Edwards Lifesciences Corporation | Mitral valve prosthesis |
US11141274B2 (en) | 2006-06-01 | 2021-10-12 | Edwards Lifesciences Corporation | Method of treating a defective heart valve |
US8968395B2 (en) | 2006-06-01 | 2015-03-03 | Edwards Lifesciences Corporation | Prosthetic insert for treating a mitral valve |
US20070282429A1 (en) * | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
US8007992B2 (en) | 2006-10-27 | 2011-08-30 | Edwards Lifesciences Corporation | Method of treating glutaraldehyde-fixed pericardial tissue with a non-aqueous mixture of glycerol and a C1-C3 alcohol |
US9918832B2 (en) | 2006-10-27 | 2018-03-20 | Edwards Lifesciences Corporation | Biological tissue for surgical implantation |
US20080262603A1 (en) * | 2007-04-23 | 2008-10-23 | Sorin Biomedica Cardio | Prosthetic heart valve holder |
US9101691B2 (en) | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
US8006535B2 (en) | 2007-07-12 | 2011-08-30 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve crimping device |
US8640521B2 (en) | 2007-07-12 | 2014-02-04 | Sorin Group Italia S.R.L. | Expandable prosthetic valve crimping device |
US20090018570A1 (en) * | 2007-07-12 | 2009-01-15 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve crimping device |
US10966823B2 (en) | 2007-10-12 | 2021-04-06 | Sorin Group Italia S.R.L. | Expandable valve prosthesis with sealing mechanism |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US10188511B2 (en) | 2007-12-21 | 2019-01-29 | Edwards Lifesciences Corporation | Bioprosthetic tissue with reduced calcification |
US8357387B2 (en) | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US7972376B1 (en) | 2007-12-21 | 2011-07-05 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US10966822B2 (en) | 2007-12-21 | 2021-04-06 | Edwards Lifesciences Corporation | Heart valve with reduced calcification |
US9029418B2 (en) | 2007-12-21 | 2015-05-12 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US8748490B2 (en) | 2007-12-21 | 2014-06-10 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US8177836B2 (en) | 2008-03-10 | 2012-05-15 | Medtronic, Inc. | Apparatus and methods for minimally invasive valve repair |
US10952846B2 (en) | 2008-05-01 | 2021-03-23 | Edwards Lifesciences Corporation | Method of replacing mitral valve |
US11717401B2 (en) | 2008-05-01 | 2023-08-08 | Edwards Lifesciences Corporation | Prosthetic heart valve assembly |
US10856858B2 (en) | 2008-11-21 | 2020-12-08 | Percutaneous Cardiovascular Solutions Pty Ltd | Heart valve prosthesis and method |
US10842476B2 (en) | 2008-11-21 | 2020-11-24 | Percutaneous Cardiovascular Solutions Pty Ltd | Heart valve prosthesis and method |
US10166014B2 (en) | 2008-11-21 | 2019-01-01 | Percutaneous Cardiovascular Solutions Pty Ltd | Heart valve prosthesis and method |
US10098733B2 (en) | 2008-12-23 | 2018-10-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US9918841B2 (en) | 2009-03-19 | 2018-03-20 | Sorin Group Italia S.R.L. | Universal valve annulus sizing device |
US20100249661A1 (en) * | 2009-03-19 | 2010-09-30 | Sorin Biomedica Cardio S.r.I | Universal Valve Annulus Sizing Device |
US8715207B2 (en) | 2009-03-19 | 2014-05-06 | Sorin Group Italia S.R.L. | Universal valve annulus sizing device |
US20100262043A1 (en) * | 2009-03-26 | 2010-10-14 | Sorin Group Usa, Inc. | Annuloplasty sizers for minimally invasive procedures |
US9149207B2 (en) | 2009-03-26 | 2015-10-06 | Sorin Group Usa, Inc. | Annuloplasty sizers for minimally invasive procedures |
US8518060B2 (en) | 2009-04-09 | 2013-08-27 | Medtronic, Inc. | Medical clip with radial tines, system and method of using same |
US8668704B2 (en) | 2009-04-24 | 2014-03-11 | Medtronic, Inc. | Medical clip with tines, system and method of using same |
US20110071622A1 (en) * | 2009-09-23 | 2011-03-24 | Fehling Instruments Gmbh & Co. Kg | Instrument for the surgical treatment of aortic valve defects |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US10092399B2 (en) | 2010-03-23 | 2018-10-09 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US11213385B2 (en) | 2010-03-23 | 2022-01-04 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US8846390B2 (en) | 2010-03-23 | 2014-09-30 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US9492230B2 (en) | 2010-03-23 | 2016-11-15 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US9498287B2 (en) | 2010-03-23 | 2016-11-22 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US9498288B2 (en) | 2010-03-23 | 2016-11-22 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US8906601B2 (en) | 2010-06-17 | 2014-12-09 | Edwardss Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
US9351829B2 (en) | 2010-11-17 | 2016-05-31 | Edwards Lifesciences Corporation | Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US11590260B2 (en) | 2012-11-08 | 2023-02-28 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
US20150351911A1 (en) * | 2013-01-25 | 2015-12-10 | Medtentia International Ltd Oy | A Medical Device And Method For Facilitating Selection Of An Annuloplasty Implant |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US11607310B2 (en) | 2017-05-12 | 2023-03-21 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US11478351B2 (en) | 2018-01-22 | 2022-10-25 | Edwards Lifesciences Corporation | Heart shape preserving anchor |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11819406B2 (en) | 2018-05-23 | 2023-11-21 | Corcym S.R.L. | Loading system for an implantable prosthesis and related loading method |
US11969341B2 (en) | 2018-05-23 | 2024-04-30 | Corcym S.R.L. | Cardiac valve prosthesis |
US11992397B2 (en) | 2018-05-23 | 2024-05-28 | Corcym S.R.L. | Holder for heart valve prosthesis, a storage arrangement for a heart valve prosthesis, and a crimping kit and method |
Also Published As
Publication number | Publication date |
---|---|
US20050215100A1 (en) | 2005-09-29 |
US7357814B2 (en) | 2008-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7357814B2 (en) | Method of determining size of cardiac prosthesis | |
US7510573B2 (en) | Sizing apparatus | |
CN111212614B (en) | Axisymmetric adjustable device for treating mitral regurgitation | |
US6419695B1 (en) | Cardiac prosthesis for helping improve operation of a heart valve | |
US7160322B2 (en) | Implantable cardiac prosthesis for mitigating prolapse of a heart valve | |
US6869444B2 (en) | Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve | |
CA2526347C (en) | Apparatus and methods for repair of a cardiac valve | |
US7901454B2 (en) | Apparatus and method for treating a regurgitant valve | |
US20080097595A1 (en) | Intraventricular cardiac prosthesis | |
US20060142848A1 (en) | Extra-anatomic aortic valve placement | |
WO2019046241A1 (en) | Transcatheter device for treating mitral regurgitation | |
US20030040793A1 (en) | Self-molding annuloplasty ring and method of use | |
US20050222675A1 (en) | Implantable prosthetic heart valve comprising a valve body and a tubular vascular graft | |
CN116196151B (en) | Preset artificial biological aortic valve | |
AU2017204546A1 (en) | Prosthetic insert for improving heart valve function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |